The role of hypoxia-inducible factors in organ donation and transplantation: The current perspective and future opportunities

American Journal of Transplantation

Volumn 14, Issue 7, 2014, Pages 1481-1487

  Akhtar, M Z ^a,b   Sutherland, A I ^c   Huang, H ^a,b   Ploeg, R J ^a   Pugh, C W ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

HIF; hypoxia; ischemia; ischemia reperfusion injury; transplant

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1;

ACUTE KIDNEY TUBULE NECROSIS; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIOVASCULAR RISK; COLD ISCHEMIA; DELAYED GRAFT FUNCTION; EX VIVO STUDY; GRAFT DYSFUNCTION; HEART TRANSPLANTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIA; ISCHEMIC PRECONDITIONING; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG EDEMA; LUNG TRANSPLANTATION; NONHUMAN; ORGAN DONOR; ORGAN PRESERVATION; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; ANOXIA; METABOLISM; TRANSPLANTATION;

ANOXIA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; ORGAN PRESERVATION; ORGAN TRANSPLANTATION; REPERFUSION INJURY; TISSUE AND ORGAN PROCUREMENT;

EID: 84903184456     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12737     Document Type: Review

References (45)

1. Maxwell PH, Pugh CW, Ratcliffe PJ., Inducible operation of the erythropoietin 3' enhancer in multiple cell lines: Evidence for a widespread oxygen-sensing mechanism. Proc Natl Acad Sci U S A 1993; 90: 2423-2427.
2. Pugh CW, Tan CC, Jones RW, Ratcliffe PJ., Functional analysis of an oxygen-regulated transcriptional enhancer lying 3' to the mouse erythropoietin gene. Proc Natl Acad Sci U S A 1991; 88: 10553-10557.
3. Wang GL, Semenza GL., General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A 1993; 90: 4304-4308.
4. Epstein AC, Gleadle JM, McNeill LA, et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001; 107: 43-54.
5. Lando D, Peet DJ, Whelan DA, Gorman JJ, Whitelaw ML., Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science 2002; 295: 858-861.
6. Kiss J, Kirchberg J, Schneider M., Molecular oxygen sensing: Implications for visceral surgery. Langenbecks Arch Surg 2012; 397: 603-610.
7. Berra E, Roux D, Richard DE, Pouysségur J., Hypoxia-inducible factor-1 alpha (HIF-1 alpha) escapes O(2)-driven proteasomal degradation irrespective of its subcellular localization: Nucleus or cytoplasm. EMBO Rep 2001; 2: 615-620.
8. Bernhardt WM, Schmitt R, Rosenberger C, et al. Expression of hypoxia-inducible transcription factors in developing human and rat kidneys. Kidney Int 2006; 69: 114-122.
9. Henze AT, Acker T., Feedback regulators of hypoxia-inducible factors and their role in cancer biology. Cell Cycle 2010; 9: 2749-2763.
10. Firth JD, Ebert BL, Pugh CW, Ratcliffe PJ., Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: Similarities with the erythropoietin 3' enhancer. Proc Natl Acad Sci U S A 1994; 91: 6496-6500.
11. Akhtar MZ, Henderson T, Sutherland A, Vogel T, Friend PJ., Novel approaches to preventing ischemia-reperfusion injury during liver transplantation. Transplant Proc 2013; 45: 2083-2092.
12. Greijer AE, van der Wall E., The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol 2004; 57: 1009-1014.
13. Pugh CW, Ratcliffe PJ., Regulation of angiogenesis by hypoxia: Role of the HIF system. Nat Med 2003; 9: 677-684.
14. Rajnoch J, Viklický O., Angiogenesis and organ transplantation. Folia Microbiol (Praha) 2004; 49: 499-505.
15. Taylor CT, Cummins EP., The role of NF-kappaB in hypoxia-induced gene expression. Ann N Y Acad Sci 2009; 1177: 178-184.
16. Rodriguez F, Bonacasa B, Fenoy FJ, Salom MG., Reactive oxygen and nitrogen species in the renal ischemia/reperfusion injury. Curr Pharm Des 2013; 19: 2776-2794.
17. Appelhoff RJ, Tian YM, Raval RR, et al. Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem 2004; 279: 38458-38465.
18. Moers C, Smits JM, Maathuis MH, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009; 360: 7-19.
19. Conde E, Alegre L, Blanco-Sánchez I, et al. Hypoxia inducible factor 1-alpha (HIF-1 alpha) is induced during reperfusion after renal ischemia and is critical for proximal tubule cell survival. PLoS ONE 2012; 7: e33258.
20. Zhang XL, Yan ZW, Sheng WW, Xiao J, Zhang ZX, Ye ZB., Activation of hypoxia-inducible factor-1 ameliorates postischemic renal injury via inducible nitric oxide synthase. Mol Cell Biochem 2011; 358: 287-295.
21. Hill P, Shukla D, Tran MG, et al. Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 2008; 19: 39-46.
22. Hu CJ, Wang LY, Chodosh LA, Brian K, Simon MC., Differential roles of hypoxia-inducible factor 1α (HIF-1α) and HIF-2α in hypoxic gene regulation. Mol Cell Biol 2003; 23: 9361-9374.
23. Yi X, Zhang G, Yuan J., Renoprotective role of fenoldopam pretreatment through hypoxia-inducible factor-1alpha and heme oxygenase-1 expressions in rat kidney transplantation. Transplant Proc 2013; 45: 517-522.
24. Yang CC, Lin LC, Wu MS, Chien CT, Lai MK., Repetitive hypoxic preconditioning attenuates renal ischemia/reperfusion induced oxidative injury via upregulating HIF-1 alpha-dependent bcl-2 signaling. Transplantation 2009; 88: 1251-1260.
25. Bernhardt WM, Gottmann U, Doyon F, et al. Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model. Proc Natl Acad Sci U S A 2009; 106: 21276-21281.
26. Baan C, van Gelder T, Peeters A, et al. Living kidney donors and hypoxia-inducible factor-1alpha. Transplantation 2003; 75: 570-571.
27. Rosenberger C, Rosen S, Heyman SN., Renal parenchymal oxygenation and hypoxia adaptation in acute kidney injury. Clin Exp Pharmacol Physiol 2006; 33: 980-988.
28. Vogel T, Brockmann JG, Coussios C, Friend PJ., The role of normothermic extracorporeal perfusion in minimizing ischemia reperfusion injury. Transplant Rev (Orlando) 2012; 26: 156-162.
29. Ben Mosbah I, Mouchel Y, Pajaud J, et al. Pretreatment with mangafodipir improves liver graft tolerance to ischemia/reperfusion injury in rat. PLoS ONE 2012; 7: e50235.
30. Schneider M, Van Geyte K, Fraisl P, et al. Loss or silencing of the PHD1 prolyl hydroxylase protects livers of mice against ischemia/reperfusion injury. Gastroenterology 2010; 138: 1143-1154.e1-2.
31. Zhong Z, Ramshesh VK, Rehman H, et al. Activation of the oxygen-sensing signal cascade prevents mitochondrial injury after mouse liver ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol 2008; 295: G823-G832.
32. Amador A, Grande L, Martí J, et al. Ischemic pre-conditioning in deceased donor liver transplantation: A prospective randomized clinical trial. Am J Transplant 2007; 7: 2180-2189.
33. Plock J, Frese S, Keogh A, et al. Activation of non-ischemic, hypoxia-inducible signalling pathways up-regulate cytoprotective genes in the murine liver. J Hepatol 2007; 47: 538-545.
34. Albrecht M, Zitta K, Bein B, et al. Remote ischemic preconditioning regulates HIF-1α levels, apoptosis and inflammation in heart tissue of cardiosurgical patients: A pilot experimental study. Basic Res Cardiol 2013; 108: 314.
35. Ong SG, Hausenloy DJ., Hypoxia-inducible factor as a therapeutic target for cardioprotection. Pharmacol Ther 2012; 136: 69-81.
36. Cai Z, Manalo DJ, Wei G, et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 2003; 108: 79-85.
37. Nwogu JI, Geenen D, Bean M, Brenner MC, Huang X, Buttrick PM., Inhibition of collagen synthesis with prolyl 4-hydroxylase inhibitor improves left ventricular function and alters the pattern of left ventricular dilatation after myocardial infarction. Circulation 2001; 104: 2216-2221.
38. Keränen MA, Tuuminen R, Syrjälä S, et al. Differential effects of pharmacological HIF preconditioning of donors versus recipients in rat cardiac allografts. Am J Transplant 2013; 13: 600-610.
39. Ten VS, Pinsky DJ., Endothelial response to hypoxia: Physiologic adaptation and pathologic dysfunction. Curr Opin Crit Care 2002; 8: 242-250.
40. Paulus P, Ockelmann P, Tacke S, et al. Deguelin attenuates reperfusion injury and improves outcome after orthotopic lung transplantation in the rat. PLoS ONE 2012; 7: e39265.
41. Chin BY, Jiang G, Wegiel B, et al. Hypoxia-inducible factor 1alpha stabilization by carbon monoxide results in cytoprotective preconditioning. Proc Natl Acad Sci U S A 2007; 104: 5109-5114.
42. Morath C, Arns W, Schwenger V, et al. Sirolimus in renal transplantation. Nephrol Dial Transplant 2007; 22 (Suppl 8): viii61-viii65.
43. Clambey ET, McNamee EN, Westrich JA, et al. Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc Natl Acad Sci U S A 2012; 109: E2784-E2793.
44. Kannan KB, Colorado I, Reino D, et al. Hypoxia-inducible factor plays a gut-injurious role in intestinal ischemia reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2011; 300: G853-G861.
45. Hart ML, Henn M, Köhler D, et al. Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J 2008; 22: 2784-2797.